Paclitaxel in the multimodality treatment for inflammatory breast carcinoma
Open Access
- 1 October 2001
- Vol. 92 (7), 1775-1782
- https://doi.org/10.1002/1097-0142(20011001)92:7<1775::aid-cncr1693>3.0.co;2-e
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Prospective Evaluation of Paclitaxel Versus Combination Chemotherapy With Fluorouracil, Doxorubicin, and Cyclophosphamide as Neoadjuvant Therapy in Patients With Operable Breast CancerJournal of Clinical Oncology, 1999
- First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial)British Journal of Cancer, 1999
- Survival after autologous hematopoietic stem cell transplantation for patients with inflammatory breast carcinomaCancer, 1999
- Inflammatory breast carcinoma incidence and survivalCancer, 1998
- High-dose multimodality therapy with autologous stem-cell support for stage IIIB breast carcinoma.Journal of Clinical Oncology, 1998
- Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer CenterCancer Chemotherapy and Pharmacology, 1997
- Mammographic patterns of inflammatory breast carcinoma: a retrospective study of 92 casesEuropean Journal of Radiology, 1997
- Combined Modality Treatment of Stage III and Inflammatory Breast CancerSurgical Oncology Clinics of North America, 1995
- Inflammatory breast carcinoma: mammographic findings.Radiology, 1994
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958